Administration Method of Adjuvant Tegafur‐Uracil and Leucovorin Calcium in Patients with Resected Colorectal Cancer: A Phase III Study

LESSONS LEARNED: The 3‐year disease‐free survival rate of the twice‐daily regimen was not inferior to that of the conventional three‐times‐daily regimen, and the twice‐daily regimen did not lead to an increase in adverse events. The effectiveness of the twice‐daily regimen highlights an increased nu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Hata, Taishi, Hagihara, Kiyotaka, Tsutsui, Anna, Akamatsu, Hiroki, Ohue, Masayuki, Shingai, Tatsushi, Tei, Mitsuyoshi, Ikenaga, Masakazu, Kim, Ho Min, Osawa, Hideki, Takemoto, Hiroyoshi, Konishi, Ken, Uemura, Mamoru, Matsuda, Chu, Mizushima, Tsunekazu, Murata, Kohei, Ohno, Yuko, Doki, Yuichiro, Eguchi, Hidetoshi
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2021
Assuntos:
Clinical Trial Results
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100551/
https://ncbi.nlm.nih.gov/pubmed/33604941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13724
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados